Incidental Mutation 'P0016:Traip'
ID |
7596 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Traip
|
Ensembl Gene |
ENSMUSG00000032586 |
Gene Name |
TRAF-interacting protein |
Synonyms |
Trip |
MMRRC Submission |
038269-MU
|
Accession Numbers |
|
Essential gene? |
Essential
(E-score: 1.000)
|
Stock # |
P0016 (G1)
|
Quality Score |
|
Status
|
Validated
|
Chromosome |
9 |
Chromosomal Location |
107828158-107849469 bp(+) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to G
at 107845855 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Aspartic acid to Glycine
at position 316
(D316G)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000040001
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000049348]
|
AlphaFold |
Q8VIG6 |
Predicted Effect |
possibly damaging
Transcript: ENSMUST00000049348
AA Change: D316G
PolyPhen 2
Score 0.928 (Sensitivity: 0.81; Specificity: 0.94)
|
SMART Domains |
Protein: ENSMUSP00000040001 Gene: ENSMUSG00000032586 AA Change: D316G
Domain | Start | End | E-Value | Type |
RING
|
7 |
49 |
6.68e-6 |
SMART |
coiled coil region
|
70 |
278 |
N/A |
INTRINSIC |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000194191
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000194538
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000195803
|
Meta Mutation Damage Score |
0.0725 |
Coding Region Coverage |
- 1x: 85.6%
- 3x: 81.0%
- 10x: 66.8%
- 20x: 50.1%
|
Validation Efficiency |
96% (97/101) |
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein that contains an N-terminal RING finger motif and a putative coiled-coil domain. A similar murine protein interacts with TNFR-associated factor 1 (TRAF1), TNFR-associated factor 2 (TRAF2), and cylindromatosis. The interaction with TRAF2 inhibits TRAF2-mediated nuclear factor kappa-B, subunit 1 activation that is required for cell activation and protection against apoptosis. [provided by RefSeq, Jul 2008] PHENOTYPE: Mice homozygous for a null allele exhibit embryonic lethality at prior to E8.5, embryonic growth retardation, decreased embryonic size, decreased cell proliferation and increased apoptosis. [provided by MGI curators]
|
Allele List at MGI |
All alleles(10) : Targeted(1) Gene trapped(9)
|
Other mutations in this stock |
Total: 18 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
1700123K08Rik |
A |
T |
5: 138,561,200 (GRCm39) |
L154* |
probably null |
Het |
4930432E11Rik |
T |
C |
7: 29,262,537 (GRCm39) |
|
noncoding transcript |
Het |
Arap3 |
T |
A |
18: 38,117,401 (GRCm39) |
T892S |
probably benign |
Het |
Ctnnd2 |
G |
A |
15: 30,967,084 (GRCm39) |
V987I |
probably benign |
Het |
Dennd6b |
T |
C |
15: 89,071,180 (GRCm39) |
I351V |
probably benign |
Het |
Kif27 |
G |
A |
13: 58,451,266 (GRCm39) |
Q1021* |
probably null |
Het |
Klb |
G |
A |
5: 65,537,266 (GRCm39) |
W865* |
probably null |
Het |
Mbd1 |
C |
T |
18: 74,407,609 (GRCm39) |
R130* |
probably null |
Het |
Mroh7 |
T |
A |
4: 106,565,054 (GRCm39) |
|
probably null |
Het |
Myo16 |
C |
T |
8: 10,450,596 (GRCm39) |
|
probably benign |
Het |
Rbm22 |
T |
A |
18: 60,703,842 (GRCm39) |
|
probably benign |
Het |
Rnaseh2a |
C |
G |
8: 85,686,429 (GRCm39) |
D206H |
probably damaging |
Het |
Slain1 |
A |
G |
14: 103,923,110 (GRCm39) |
T187A |
probably benign |
Het |
Slamf6 |
A |
G |
1: 171,764,068 (GRCm39) |
T154A |
probably damaging |
Het |
Ttn |
T |
C |
2: 76,641,527 (GRCm39) |
D5196G |
probably damaging |
Het |
Ubr5 |
C |
T |
15: 38,000,822 (GRCm39) |
V1569M |
probably damaging |
Het |
Zfp750 |
T |
A |
11: 121,404,804 (GRCm39) |
K24* |
probably null |
Het |
Zfp799 |
T |
C |
17: 33,038,331 (GRCm39) |
E645G |
possibly damaging |
Het |
|
Other mutations in Traip |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL00088:Traip
|
APN |
9 |
107,847,749 (GRCm39) |
missense |
probably benign |
0.15 |
IGL01457:Traip
|
APN |
9 |
107,847,671 (GRCm39) |
missense |
probably benign |
0.00 |
IGL01597:Traip
|
APN |
9 |
107,833,123 (GRCm39) |
critical splice donor site |
probably null |
|
IGL02197:Traip
|
APN |
9 |
107,845,936 (GRCm39) |
missense |
possibly damaging |
0.89 |
IGL03077:Traip
|
APN |
9 |
107,840,125 (GRCm39) |
unclassified |
probably benign |
|
IGL03226:Traip
|
APN |
9 |
107,848,192 (GRCm39) |
missense |
probably damaging |
0.97 |
BB008:Traip
|
UTSW |
9 |
107,848,241 (GRCm39) |
missense |
probably benign |
0.04 |
BB018:Traip
|
UTSW |
9 |
107,848,241 (GRCm39) |
missense |
probably benign |
0.04 |
R1693:Traip
|
UTSW |
9 |
107,847,229 (GRCm39) |
missense |
probably damaging |
0.99 |
R2054:Traip
|
UTSW |
9 |
107,840,118 (GRCm39) |
missense |
probably benign |
0.08 |
R4396:Traip
|
UTSW |
9 |
107,836,686 (GRCm39) |
missense |
probably benign |
0.02 |
R4617:Traip
|
UTSW |
9 |
107,847,218 (GRCm39) |
missense |
probably benign |
0.00 |
R6151:Traip
|
UTSW |
9 |
107,847,818 (GRCm39) |
critical splice donor site |
probably null |
|
R6241:Traip
|
UTSW |
9 |
107,845,933 (GRCm39) |
missense |
probably benign |
0.33 |
R6920:Traip
|
UTSW |
9 |
107,838,240 (GRCm39) |
nonsense |
probably null |
|
R7177:Traip
|
UTSW |
9 |
107,838,184 (GRCm39) |
missense |
possibly damaging |
0.62 |
R7191:Traip
|
UTSW |
9 |
107,847,216 (GRCm39) |
missense |
probably benign |
|
R7504:Traip
|
UTSW |
9 |
107,838,743 (GRCm39) |
missense |
probably benign |
0.05 |
R7931:Traip
|
UTSW |
9 |
107,848,241 (GRCm39) |
missense |
probably benign |
0.04 |
R7939:Traip
|
UTSW |
9 |
107,833,077 (GRCm39) |
missense |
probably benign |
0.21 |
R8228:Traip
|
UTSW |
9 |
107,838,265 (GRCm39) |
missense |
probably benign |
0.16 |
R9059:Traip
|
UTSW |
9 |
107,840,549 (GRCm39) |
missense |
probably benign |
0.01 |
R9511:Traip
|
UTSW |
9 |
107,838,785 (GRCm39) |
missense |
probably damaging |
1.00 |
R9548:Traip
|
UTSW |
9 |
107,833,099 (GRCm39) |
missense |
probably damaging |
1.00 |
X0018:Traip
|
UTSW |
9 |
107,838,855 (GRCm39) |
critical splice donor site |
probably null |
|
|
Protein Function and Prediction |
TRAIP (alternatively, TRIP) is a RING-type E3 ubiquitin ligase that interacts with TRAF and functions to repress NF-κB signaling to regulate proliferation and differentiation [(1); reviewed in (2)]. Also, TRAIP interacts with Syk, a non-receptor protein kinase that acts as a tumor suppressor (3). This interaction reduces the Syk-mediated increase in TNFα-dependent activation of NF-κB (4). TRAIP also interacts with the tumor suppressor CYLD (5).
|
Expression/Localization |
Northern blot analysis of mouse tissues identified the Traip transcript in testis, thymus, and spleen (6). In keratinocytes undergoing differentiation (7) as well as in an immortalized monocytic cell line (1), Traip is downregulated.
|
Background |
siRNA-mediated knockdown of TRIP resulted in decreased keteratinocyte proliferation and cell cycle arrest at the G1/S phase (7).
Traiptm1Jarh/tm1Jarh; MGI:3764469
C57BL/6J
Homozygous mice are embryonic lethal by E8.5 (8). Embryos examined at earlier time-points are decreased in size, have loss of embryonic tissues, absent proamniotic cavity, increased apoptosis, and decreased cell proliferation (8).
|
References |
5. Regamey, A., Hohl, D., Liu, J. W., Roger, T., Kogerman, P., Toftgard, R., and Huber, M. (2003) The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor kappaB Activation by Tumor Necrosis Factor. J Exp Med. 198, 1959-1964.
7. Almeida, S., Ryser, S., Obarzanek-Fojt, M., Hohl, D., and Huber, M. (2011) The TRAF-Interacting Protein (TRIP) is a Regulator of Keratinocyte Proliferation. J Invest Dermatol. 131, 349-357.
8. Park, E. S., Choi, S., Kim, J. M., Jeong, Y., Choe, J., Park, C. S., Choi, Y., and Rho, J. (2007) Early Embryonic Lethality Caused by Targeted Disruption of the TRAF-Interacting Protein (TRIP) Gene. Biochem Biophys Res Commun. 363, 971-977.
|
Posted On |
2012-10-05 |
Science Writer |
Anne Murray |